NOV (NYSE:NOV) Stock

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

NOV Inc

Sunnova Energy International Inc. Common Stock

Sunnova Energy International Inc

Novation Companies Inc

First Trust Exchange-Traded Fund VIII FT Vest U.S. Equity Max Buffer ETF - November

NVN Liquidation Inc

PGIM S&P 500 Buffer 12 ETF - November

Nova Royalty Corp Ordinary Shares

Novanta Inc

Nova Vision Acquisition Corp

NOVA VISION ACQUISITION CORP USD RTS

Nova Vision Acquisition Corp Unit (1 Ordinary share , 1 Wrt & 1 Rts)

Nova Vision Acquisition Corp Warrants (31/12/2028)

TrueShares Structured Outcome (November) ETF

WIIM

HESM

MTDR

SHEL

Shares of energy stocks are up as oil prices rise amid US sanctions on Iran.

Throughout the last three months, 8 analysts have evaluated NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $18.62, a high estimate of $23.00, and a low estimate of $13.00. A 2.0% drop is evident in the current average compared to the previous average price target of $19.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744743665_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of NOV by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Stephen Gengaro &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $23.00&#x7C;$25.00 &#x7C; 
&#x7C;Charles Minervino &#x7C;Susquehanna &#x7C;Lowers &#x7C;Positive &#x7C; $19.00&#x7C;$21.00 &#x7C; 
&#x7C;Neil Mehta &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Sell &#x7C; $13.00&#x7C;$16.00 &#x7C; 
&#x7C;Keith Mackey &#x7C;RBC Capital &#x7C;Maintains &#x7C;Outperform &#x7C; $22.00&#x7C;$22.00 &#x7C; 
&#x7C;David Anderson &#x7C;Barclays &#x7C;Raises &#x7C;Underweight &#x7C; $13.00&#x7C;$12.00 &#x7C; 
&#x7C;Luke Lemoine &#x7C;Piper Sandler &#x7C;Raises &#x7C;Neutral &#x7C; $18.00&#x7C;$17.00 &#x7C; 
&#x7C;James Rollyson &#x7C;Raymond James &#x7C;Raises &#x7C;Outperform &#x7C; $19.00&#x7C;$18.00 &#x7C; 
&#x7C;Keith Mackey &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $22.00&#x7C;$21.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NOV. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NOV compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for NOV's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into NOV's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NOV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on NOV analyst ratings.</a>
<h2>Delving into NOV's Background</h2>
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
<h3>Unraveling the Financial Story of NOV</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: NOV's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -1.49%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 6.93%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): NOV's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.49%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): NOV's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.4%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: NOV's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.37.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Verdict: NOV In The Eyes Of 8 Experts

Stifel analyst Stephen Gengaro maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Buy and lowers the price target from $25 to $23.

News

Price Target

Stifel Maintains Buy on NOV, Lowers Price Target to $23

Susquehanna analyst Charles Minervino maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Positive and lowers the price target from $21 to $19.

Susquehanna Maintains Positive on NOV, Lowers Price Target to $19

Goldman Sachs analyst Neil Mehta maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Sell and lowers the price target from $16 to $13.

Goldman Sachs Maintains Sell on NOV, Lowers Price Target to $13

AESI

BORR

CIVI

CRGY

CTRA

DINO

EQNR

FANG

GLNG

LBRT

PAGP

PTEN

PUMP

SDRL

TALO

TRGP

VNOM

WFRD

Shares of energy companies are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

CLMT

HAFN

LTBR

Shares of energy stocks are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Across the recent three months, 6 analysts have shared their insights on NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for NOV, revealing an average target of $18.67, a high estimate of $22.00, and a low estimate of $13.00. Observing a downward trend, the current average is 2.61% lower than the prior average price target of $19.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1742846413_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive NOV is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$13.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Lemoine</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>James West</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$18.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to NOV. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of NOV compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for NOV's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into NOV's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NOV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on NOV analyst ratings.</a>
<h2>Get to Know NOV Better</h2>
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
<h3>Financial Milestones: NOV's Journey</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: NOV's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -1.49%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: NOV's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.93%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.49%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 1.4%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.37.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About NOV Stock

NOV shares are trading higher after RBC Capital upgraded the stock from Sector Perform to Outperform.

RBC Capital analyst Keith Mackey upgrades NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) from Sector Perform to Outperform and maintains the price target from $22 to $22.

Upgrades

RBC Capital Upgrades NOV to Outperform, Maintains Price Target to $22

Management

NOV Promotes Jose Bayardo To President & COO And Rodney Reed To Senior Vice President & CFO

Shares of companies in the broader energy sector are trading lower after president Trump confirmed Mar 4 tariffs, which could affect demand outlook.

Barclays analyst David Anderson maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Underweight and raises the price target from $12 to $13.

Barclays Maintains Underweight on NOV, Raises Price Target to $13

Piper Sandler analyst Luke Lemoine maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Neutral and raises the price target from $17 to $18.

Piper Sandler Maintains Neutral on NOV, Raises Price Target to $18

CGBS

PTLE

Shares of oil and gas companies are trading lower after President Trump reiterated a pledge to increase oil production.

In the preceding three months, 6 analysts have released ratings for NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $18.0, along with a high estimate of $22.00 and a low estimate of $12.00. Experiencing a 10.0% decline, the current average is now lower than the previous average price target of $20.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1738868445_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive NOV is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>James West</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$18.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$12.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Waqar Syed</td>
<td>ATB Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$19.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NOV. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NOV compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of NOV's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of NOV's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/NOV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on NOV analyst ratings.</a>
<h2>About NOV</h2>
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
<h3>NOV: Financial Performance Dissected</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: NOV's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.27%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: NOV's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 5.93%, the company may face hurdles in effective cost management.
Return on Equity (ROE): NOV's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.02%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): NOV's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.14%, the company may face hurdles in achieving optimal financial returns.
Debt Management: NOV's debt-to-equity ratio is below the industry average at 0.37, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying NOV: Insights From 6 Analyst Reviews

Raymond James analyst James Rollyson maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Outperform and raises the price target from $18 to $19.

Raymond James Maintains Outperform on NOV, Raises Price Target to $19

RBC Capital analyst Keith Mackey maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Sector Perform and raises the price target from $21 to $22.

RBC Capital Maintains Sector Perform on NOV, Raises Price Target to $22

NOV shares are trading higher after the company reported better-than-expected Q4 financial results.

For 2025, NOV expects a more challenging macro environment and geopolitical uncertainties to result in flat-to-lower global industry activity. However, the company expect that growing backlog of higher margin offshore production-related capital equipment, along with continued market adoption of its new technologies, will enable it to continue to improve profitability and generate healthy levels of cash flow through the year.

Guidance

NOV Expects Q1 Consolidated Revenues To Be Down 1% - 3% YoY With Adjusted EBITDA Of $235M - $265M

Press Releases

NOV Announces Third Quarter 2024 Earnings Conference Call

NOV Reports Third Quarter 2024 Results

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

NOV Declares Regular Quarterly Dividend

NOV Appoints Chris Kendall to the Board of Directors

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

NOV Announces First Quarter 2025 Earnings Conference Call

NOV Announces Key Leadership Changes

ProFrac Holding Corp. - Class A Common Stock

ProFrac Holding

Atlas Energy Solutions

Aris Water Solutions, Inc. Class A Common Stock

Aris Water Solutions

Archrock

Baker Hughes

ChampionX

Flowco Holdings Inc. Class A Common Stock

Flowco Holdings

TechnipFMC

Halliburton

Helix Energy Solutions Group, Inc. Common Stock

Helix Energy Solns Gr

Innovex International

Kodiak Gas Services

Liberty Energy

National Energy Services Reunited Corp - Ordinary Shares

National Energy Services

Oceaneering International, Inc. Common Stock

Oceaneering International

Solaris Energy Infrastructure, Inc. Class A Common Stock

Solaris Energy

Schlumberger

Tidewater

Tenaris

USA Compression Partners, LP Common Units Representing Limited Partner Interests

Comments

NOV

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL